Before joining Sequoia Capital China, Mr. Lu served as a healthcare partner at Shenzhen Co-Win Venture Capital Investment Limited, focusing on healthcare investment. During his seven years in Co-Win Venture Capital, he led over 30 healthcare investments, including: BGI (SZSE:300676), Betta Pharmaceuticals (SZSE:300558), Jingfeng Pharmaceuticals (SZSE:000908), Konruns Pharmaceuticals (listing applications submitted), Chipscreen, Innovent, Zhongankang (acquired and gone private), etc. Prior to Co-Win Venture Capital, Mr. Lu had 15 years of experience in pharmaceutical sales and marketing. He worked in China Resource Sanjiu for almost ten years.

Mr. Lu received a bachelor’s degree in biochemistry engineering from Zhejiang University and an MBA degree from Tsinghua University.